SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in halting advanced lung cancer
Disease control OngoingThis study tests a combination of two immunotherapy drugs (zimberelimab and domvanalimab) as a first treatment for people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. The goal is to see if the combination can slow or stop cancer growth …
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 16, 2026 23:51 UTC
-
Custom-Made vaccine targets tough cancers in early trial
Disease control TerminatedThis early-phase trial tested a personalized vaccine (PANDA-VAC) made from a patient's own tumor markers, given alongside the immunotherapy drug pembrolizumab. It involved 6 adults with advanced squamous lung or head/neck cancers that could not be cured. The main goal was to chec…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC